EVENTS | VIEW CALENDAR
Live-cell, real-time monitoring of cAMP kinetics
Promega Corp. announces the launch of its cell-based biosensor technology, termed GloSensor Technology. The non-lytic, live-cell GloSensor cAMP Assay is the first application of the patent-pending technology, which features a genetically engineered form of firefly luciferase. The benefit to screeners and scientists alike will be more biologically relevant data captured directly from living cells. GloSensor cAMP Assay is the first bioluminescent cell-based biosensor for the direct, intracellular kinetic monitoring of cAMP, and ideally suited to HTS and uHTS applications. Because researchers simply combine cells, compounds and GloSensor cAMP Assay Reagent, the technology offers 'zero-step' assay potential.